RightFit
RecruitingNot applicable

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Decision Making Tool for Contralateral Prophylactic Mastectomy

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "OUTLINE: Patients use decision making tool during consultation with breast cancer surgeon and complete questionnaires before and after consultation."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a tool to help people with newly diagnosed breast cancer decide about surgery to remove the other breast to prevent cancer. It looks at how well the tool helps with this choice and whether patients find it acceptable.

This trial studies the acceptability and how well decision making tool works in supporting decision making in contralateral prophylactic mastectomy in patients with newly diagnosed breast cancer. Decision making tool may help patients with early stage breast cancer make decisions regarding their surgical options.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Newly diagnosed with DCIS (cancer cells that stay inside the breast milk ducts) or stage I–III breast cancer that has spread into nearby breast tissue, is in only one breast, and is not linked to an inherited pattern.
  • Able to speak, read, or write English.

Who can't join

  • Have had breast cancer before.
  • Have already had both breasts removed to prevent cancer.
  • Have a known inherited gene change that raises breast cancer risk, such as BRCA1 or BRCA2, or a strong family history of cancer that puts you at high risk for cancer in the other breast.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Newly diagnosed ductal breast carcinoma in situ (DCIS) or stage I-III sporadic unilateral invasive breast cancer * Able to speak read or write English Exclusion Criteria: * Patients with previous breast cancer * Prior history of bilateral prophylactic mastectomy * Known to have a germline mutation that predisposes them to an increased risk of breast cancer (e.g. BRCA1/2) and/or they are considered at high risk for contralateral breast cancer on the basis of a strong family history of cancer

Study sites (1)

TX